X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Alopecia Treatment (Hair Loss) Companies

This report lists the top Alopecia Treatment (Hair Loss) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Alopecia Treatment (Hair Loss) industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Immune System Drugs Research Autoimmune Disorders Research Androgenetic Alopecia Industry Companies

Alopecia Treatment (Hair Loss) Top Companies

  1. Sun Pharmaceuticals Industries Ltd.

  2. Johnson & Johnson

  3. Concert Pharmaceuticals Inc.

  4. Cipla Inc.

  5. Daiichi Sankyo

*Disclaimer: Top companies sorted in no particular order

Alopecia Treatment (Hair Loss) Market Major Players

Alopecia Treatment (Hair Loss) Market Concentration

Alopecia Treatment (Hair Loss) Market Concentration

Alopecia Treatment (Hair Loss) Company List

                                • Aclaris Therapeutics Inc.

                                • Cipla Inc.

                                • Concert Pharmaceuticals Inc.

                                • Daiichi Sankyo Inc.

                                • GlaxoSmithKline PLC

                                • HCell Inc.

                                • Johnson & Johnson

                                • Merck & Co. Inc.

                                • Sun Pharmaceuticals Industries Ltd


                            Specific to Alopecia Treatment (Hair Loss) Market
                            Need More Details On Market Players And Competitors?
                            Download Sample

                            Alopecia Treatment (Hair Loss) Market Report Snapshots

                            Alopecia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)